Rexulti

Rexulti (brexpiprazole) is a prescription medication used to treat Major depression (add-on), schizophrenia, agitation in dementia. An oral antipsychotic used as an add-on for major depression, for schizophrenia, and for agitation with Alzheimer's dementia.

Modulates dopamine and serotonin receptor activity to help regulate mood and reduce psychotic symptoms.

Commonly reported side effects of Rexulti include Weight gain, Restlessness, Drowsiness, Movement disorders, and Increased mortality in dementia patients. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Rexulti carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Rexulti is brexpiprazole, which belongs to a class of medicines known as Atypical Antipsychotic.

Rexulti is manufactured by Otsuka/Lundbeck. It was first approved in 2015.

You may be able to lower the cost of Rexulti by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.